There is no such thing as “hepatocellular carcinoma is the mildest among liver cancers”. Whether hepatocellular carcinoma is serious or not depends on the stage and the pathologic type.
Hepatocellular carcinoma is divided into hepatocellular carcinoma and intrahepatic cholangiocarcinoma, and hepatocellular carcinoma is the most common malignant tumor of liver, accounting for about 90%. If liver cancer is in early stage, especially small liver cancer of <3cm, it can be found in time and can be completely cured by surgery.
If hepatocellular carcinoma is in the middle stage and there is a chance of surgery, it can be surgically resected and assisted with radiotherapy and targeted therapy to improve the 5-year survival rate. For advanced hepatocellular carcinoma, it should also be actively given treatment to slow down the quality of patient’s survival and prolong the survival time for the purpose.
In addition, hepatocellular carcinoma is divided into high, intermediate and low differentiation, and generally high differentiated hepatocellular carcinoma has the best prognosis.
At present, it is believed that clinical data suggests that there is a close relationship between the development of hepatocellular carcinoma and cirrhosis and viral hepatitis. Patients suffering from such diseases should regularly review liver function and color ultrasound, so as to achieve early detection and early treatment.